Le Lézard
Classified in: Health
Subjects: SVY, NTA, DEI

Centraide of Greater Montreal: $61.8M invested in 2022-2023, or 25% more than two years ago


MONTREAL, June 14, 2023 /CNW/ - Centraide of Greater Montreal invested $61.8 million in 2022-2023 to support over 350 community agencies and projects at work in the neighbourhoods of Montreal, Laval and the South Shore. This is the result revealed in the Report to Our Community released last night at Centraide's annual general meeting. This amount mainly came from donations from Major Donors, companies, institutions, workplace employees, unions, and the general public. Because of their generosity, Centraide can invest even more in the community and is contributing 25% more in funding than it did two years ago.*

With these investments, Centraide can help agencies in their work to support people living in poverty and social exclusion. It can also keep developing strategic collaborations to better meet community needs and act on the causes of disadvantage.

"We've had to tackle many challenges in recent months: the housing crisis, greater food insecurity than before the pandemic, an unprecedented surge in asylum seekers, young people reeling from the health crisis, families hit by the worst inflation in 40 years, and a community sector under great strain. Thanks to our regular investments, to our emergency funds for food security and for asylum seekers, as well as to the Youth Success Project, the Collective Impact Project and DATAide, Centraide has been able to meet these challenges head on," said Claude Pinard, President and Executive Director, Centraide of Greater Montreal.

More support for agencies and people in need

Over the past year, Centraide has further cemented its support for the community sector by: 

The many faces of poverty

Poverty and social exclusion have many faces. Despite a good economic climate and full employment, some people still find themselves in difficult situations. Centraide will continue to refine its understanding of needs and target its investments to deal with concerning social issues such as:

(*excluding the COVID emergency funds)

About Centraide of Greater Montreal  

A true agent of change, Centraide of Greater Montreal takes action in the territories of Laval, Montreal and the South Shore. It regularly supports a network of over 350 agencies and collective projects every year. Centraide is supported by businesses and organizations as well as the general public. It implements strategies and actions to break the cycle of poverty and social exclusion to improve the living conditions of vulnerable people. Last year, Centraide invested $61.8 million in the community, which represents over 86% of the money raised from its annual campaign. Over 800,000 people are helped each year by the agencies supported by Centraide of Greater Montreal. To learn more: centraide-mtl.org. 

SOURCE Centraide of Greater Montreal


These press releases may also interest you

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

at 01:30
The global urinary catheters market  size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63%  during the forecast period. ...

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: